Riskpilot← Back to searchSign inGet full accessPipeline Bioresearch ApS
APSIn liquidationCVR 37831735Marselisborg Havnevej 36Ikke-finansielle holdingselskaber · NACE 642020Est. 20162 employees
Revenue 2023
DKK -67K
EBITDA margin
192.4%
+44% vs 2022
Equity ratio
45.9%
Financial strength
Net profit 2023
DKK -171K
+27% vs 2022
| Revenue | DKK -67K | — |
| EBITDA | DKK -129K | +44% |
| Net profit | DKK -171K | +27% |
| Total assets | DKK 256K | -25% |
| Equity | DKK 118K | -59% |
| Employees | 2 | — |
Legal name
Pipeline Bioresearch ApS
CVR number
37831735
Legal form
Anpartsselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
27. juni 2016
Share capital
DKK 50.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Marselisborg Havnevej 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.026 | 3.495 | 4.202 | 2.023 | 1.612 | 1.430 | 0 | -67 |
| Staff expenses | -1.112 | -1.945 | -1.822 | -2.029 | -1.570 | -1.413 | -0 | -62 |
| EBITDA | 579 | 68 | 14 | -6 | 42 | 17 | -231 | -129 |
| Depreciation & amort. | -11 | -20 | -16 | -7 | -12 | -11 | -0 | -0 |
| EBIT | 568 | 47 | -2 | -14 | 30 | 6 | -231 | -129 |
| Net financials | -2 | -3 | -2 | -4 | -3 | -4 | -4 | -41 |
| Profit before tax | 566 | 44 | -5 | -17 | 27 | 3 | -235 | -171 |
| Tax | 127 | 10 | -0 | -0 | 1 | 1 | -0 | -0 |
| Net profit | 438 | 35 | -5 | -17 | 26 | 2 | -235 | -171 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1.526 | 2.058 | 3.138 | 2.780 | 2.494 | 552 | 341 | 256 |
| Equity | 488 | 523 | 518 | 501 | 521 | 523 | 288 | 118 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.038 | 1.535 | 2.620 | 2.279 | 1.973 | 29 | 53 | 139 |
| Total debt | 1.038 | 1.535 | 2.620 | 2.279 | 1.973 | 29 | 53 | 139 |
EBITDA margin
-12909700.0%
This company
15.8%
Market median
-81707062% vs market
20162023
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20162023
Return on equity
-144.8%
This company
18.4%
Market median
-887% vs market
20162023
Net profit margin
-17053800.0%
This company
8.1%
Market median
-210540841% vs market
20162023
Asset turnover
-0.26×
This company
1.12×
Market median
-123% vs market
20162023
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20162023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-06-27 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BS Management | Management | 2018 | — | — |
KF Unofficial title | Unofficial title | 2022 | — | — |
KH Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DERMAISSUE ApS | Company | 25.0% | 25.0% | 2016 |
GL 2016 Holding ApS | Company | 25.0% | 25.0% | 2016 |
MARSELIS KAPITAL A/S | Company | 25.0% | 25.0% | 2016 |
Tryagain Holding ApS | Company | 25.0% | 25.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pipeline Bioresearch ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Brian Sørensen | Management | 0 companies |
| Keld Friis | Unofficial title | 0 companies |
| Klaus Hartnack Kristensen | Chief Executive Officer | 0 companies |
| Lone Bruhn Madsen | Board of Directors | 0 companies |
| Gitte Laursen | Board of Directors | 0 companies |